The clinical course of nine cystic fibrosis patients homozygous for the CF gene nonsense mutation R1162X was investigated. Since this mutation should lead to an interruption in the synthesis of the cystic fibrosis transmembrane regulator (CFTR) protein, a severe clinical course was expected. All patients showed pancreatic insufficiency, while the course of the lung disease was mild to moderate. These results suggest that this form of truncated CFTR protein, still containing the regulatory region, the first ATP binding domain, and both transmembrane domains, could be partially working in the lung tissues.
Among them, the RI 162X nonsense mutation"5 is relatively frequent in north-eastern Italy'4; therefore patients carrying this mutation on both their genes are more easily found. The R1 162X mutation is characterised by the substitution of the amino acid arginine in position 1162 of CFTR with a UGA termination codon. '5 Here we report our results on the correlation between the Rl 162X mutation and the clinical manifestations of cystic fibrosis, including meconium ileus, pancreatic function, lung involvement, growth rate, etc, as shown by the nine patients identified so far in our population who are homozygotes for the mutation. The possible pathophysiological role of the Rl 162X mutation is discussed.
Cystic fibrosis (CF) is an autosomal recessive disease with a prevalence of about 1 in 2000 live births and a carrier frequency of approximately 1 in 23 in Caucasian populations.' At the end of 1989, the cystic fibrosis gene was identified. On the basis of the nucleotide sequence, the CF gene was predicted to encode a 1480 amino acid membrane glycoprotein, the 'cystic fibrosis transmembrane conductance regulator' (CFTR).2-4 The deduced amino acid sequence suggests that CFTR has several functionally important regions, including two ATP binding domains, two transmembrane domains, and a highly charged domain with several potential sites for phosphorylation by protein kinases. Its structure shows homology with the ATP binding cassette transport systems. 5 The function of CFTR is still unknown, even if recent studies confirm that it may well be involved in cAMP activated chloride ion transport. 67 The identification of naturally occurring deleterious gene mutations and the characterisation of their relation to disease phenotypes could help us to understand the functional importance of CFTR and of its putative domains. For this purpose, patients homozygous for a specific mutation are needed, in which the phenotypic expression of the disease may be ascribed to that specific gene alteration. Unfortunately, a useful number of homozygous patients can be collected only when the particular mutation being investigated reaches a high frequency in a given population. Therefore, only the clinical correlation of the most common CF mutation, AF508,''0 has been described in detail so far.'-"-" Pulmonary radiographs were evaluated using the Chrispin-Norman score23: it ranges from 0 (no damage) to 38 which is the worst score. Onset of Pseudomonas colonisation was defined as the first 6 month period in which sputum cultures were repeatedly positive for Pseudomonas aeruginosa.
ASSESSMENT OF THE DEGREE OF PULMONARY DISEASE
In order to define the degree of pulmonary disease of the Rl 162X homozygotes, their last chest radiograph score values were compared to the longitudinal score centiles of a cohort of CF patients. This cohort consisted of all the CF patients diagnosed in the Veneto and Trentino regions from 1.10.73 to 31.12.81 and all treated at the Verona CF Centre. They were checked by chest radiography nearly every six months. The 25th, 50th, and 75th centiles of the Chrispin-Norman score values were computed for 20 month subgroups from 50 to 210 months of age (individual scores within the subgroups were averaged).
Furthermore the last Chrispin-Norman score values of the nine Rl 162X homozygotes were compared to the last score values of 37 unselected AF508 homozygotes.
Results
Out of 187 unrelated patients analysed for the presence of the AF508 and Rl 162X mutations, nine homozygotes for the latter mutation were found, including a couple of brothers. Their present ages range from 5 to about 24 years.
The clinical features of these patients are shown in the table. Two of them (nos 1 and 3) were detected through neonatal screening performed with blood spot immunotrypsin and meconium lactase assays.24 Two were diagnosed through meconium ileus (nos 4 and 9), four through digestive symptoms, and only one through respiratory as well as digestive ones (no 6). One of them (no 5) had borderline sweat test results.
All the patients showed pancreatic involvement at birth. The exocrine pancreatic function, investigated in six cases by duodenal intubation, was characterised by very decreased output of enzymes and bicarbonate, and a high degree of fat loss was shown in all nine patients: all had been treated with pancreatic enzyme supplementation since diagnosis. Only two adolescent subjects had poor nutritional status (nos 5 and 7) and another had very short stature at 12-7 years.
The onset of respiratory symptoms occurred in all but one of the subjects after the first year of life. One of them developed pneumothorax at 16 years; he is now 18 years old and no important deterioration in respiratory function or symptoms has been observed so far. No other major respiratory complications like haemoptysis or lobar atelectasis were recorded in the whole group. Nasal polyposis was present in two sibs (nos 3 and 7) and allergic bronchopulmonary aspergillosis (ABPA) occurred in two cases (nos 4 and 5) .
Lung function at the last test showed a moderately obstructive picture in three patients (nos 5, 6, and 7); there was mild obstruction in the oldest patients (nos 8 and 9) and normal or near normal respiratory function in the youngest ones (nos 2, 3, and 4). The individual chest x ray score at the last visit was compared to that of a CF cohort (fig 1) : eight out of nine patients showed values lower than the 50th centile of the reference CF population. AF508 frequency in the cohort was 48%. When compared to an unselected group of AF508 homozygotes the x ray scores of the R1162X homozygotes were in the mid-low range of the reference group (fig 2) . (fig 1) , in which chest tion.'4 In both cases an opal termination x ray evaluation was performed longitudinally codon is involved. In the pulmonary epithelial 
